Review
Sep 2026
Rivastigmine-centered molecular hybridization strategies for multi-targeted intervention in Alzheimer's disease: Advances (2020-2026).
This review comprehensively summarizes and critically analyzes advances reported from 2020 to 2026 in the design, synthesis, biological evaluation, and therapeutic potential of RIV-based hybrid molecules and scaffold modifications for AD treatment.
Nitin Kumar, V. Kushwaha, Gourav Singh et al.
· Bioorganic & Medicinal Chemi... · 0 citations